Cryoport CEO exercises options for 50,000 shares

Cryoport, Inc. President and CEO Jerrell Shelton exercised stock options and increased his direct share ownership.

Rhea-AI Filing Summary

Cryoport, Inc. President and CEO Jerrell Shelton exercised stock options and increased his direct share ownership. On the transaction date, he exercised options to purchase 50,000 shares of common stock at an exercise price of $1.87 per share, receiving 50,000 common shares.

Following the transactions, Shelton directly held 1,126,607 shares of Cryoport common stock and 104,007 options to purchase common stock. The exercised options were part of a grant that vested in equal 1/48 installments each month over forty-eight months beginning on May 6, 2016, with the options expiring on May 6, 2026.

Insider Trade Summary

50,000 shares exercised/converted

Exercise 2 txns

Insider SHELTON JERRELL

Role President, CEO

Type	Security	Shares	Price	Value
Exercise	Options to purchase common stock	50,000	$0.00	$0.00
Exercise	Common Stock	50,000	$1.87	$94K

Holdings After Transaction: Options to purchase common stock — 104,007 contracts (Direct); Common Stock — 1,126,607 shares (Direct)

Footnotes (1)

1. F1. 1/48 of options vested on the 6th of each month for forty-eight months beginning May 6, 2016.

Key Figures

Options exercised: 50,000 shares Exercise price: $1.87 per share Shares held after: 1,126,607 shares +3 more

6 metrics

Options exercised 50,000 shares Options to purchase common stock exercised on 2026-04-06

Exercise price $1.87 per share Strike price of options converted into common stock

Shares held after 1,126,607 shares Common stock directly owned by Shelton after transactions

Options remaining 104,007 options Options to purchase common stock following the exercise

Option expiration May 6, 2026 Expiration date of the option grant

Vesting schedule 1/48 monthly over 48 months Vesting from May 6, 2016 for the option grant

Key Terms

Options to purchase common stock, derivative security, vesting, exercise price, +1 more

5 terms

Options to purchase common stock financial

"security_title: Options to purchase common stock"

derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

vesting financial

"1/48 of options vested on the 6th of each month"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

exercise price financial

"conversion_or_exercise_price: 1.8700"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: 2026-05-06"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Cryoport (CYRX) CEO Jerrell Shelton report?

Jerrell Shelton reported exercising stock options to acquire 50,000 shares of Cryoport common stock. The options had an exercise price of $1.87 per share, and the transaction increased his direct equity stake in the company.

How many Cryoport (CYRX) shares does Jerrell Shelton hold after this Form 4?

After the reported transactions, Jerrell Shelton directly holds 1,126,607 shares of Cryoport common stock. He also holds 104,007 options to purchase additional common shares, reflecting his ongoing long-term equity exposure to the company.

What was the exercise price of the Cryoport (CYRX) options exercised by the CEO?

The options exercised by Jerrell Shelton had an exercise price of $1.87 per share. Exercising these derivative securities converted 50,000 option rights into 50,000 shares of Cryoport common stock at that fixed strike price.

Did the Cryoport (CYRX) CEO sell any shares in this Form 4 filing?

No, the Form 4 shows only option exercises and acquisitions of shares, with no reported sales. The transactions are coded as derivative exercises, meaning Shelton increased his direct share ownership rather than disposing of shares.

What is the vesting schedule of the Cryoport (CYRX) options exercised by Jerrell Shelton?

The exercised options vested over time, with 1/48 of the grant vesting on the 6th of each month for forty-eight months starting May 6, 2016. This structure reflects a long-term, time-based compensation arrangement for the executive.

When do the exercised Cryoport (CYRX) options held by the CEO expire?

The options exercised by Jerrell Shelton carried an expiration date of May 6, 2026. Exercising them before this date converted the derivative securities into common stock, aligning his compensation more directly with long-term shareholder value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/08/2026 - 06:32 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SHELTON JERRELL

(Last) (First) (Middle)

C/O CRYOPORT INC.

112 WESTWOOD PLACE, SUITE 350

(Street)

BRENTWOOD TENNESSEE 37027

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cryoport, Inc. [ CYRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/06/2026		M		50,000	A	$1.87	1,126,607	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options to purchase common stock	$1.87	04/06/2026		M			50,000	(1)	05/06/2026	Common Stock	50,000	$0	104,007	D

Explanation of Responses:

1. 1/48 of options vested on the 6th of each month for forty-eight months beginning May 6, 2016.

	/s/ Jerrell Shelton	04/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)